GlassScriptPhysician profile
Andrew D Penn
NPI 1861564312
$20,994.96
in general payments reported to CMS, 2019-2025
12 companies · $9,803 in 2025
The $9,803 reported for 2025 was more than what 99% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.58 · 2023: $384 · 2024: $11K · 2025: $9,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $2,731 · Travel and Lodging: $2,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,592.30 |
| Food and Beverage | $2,730.83 |
| Travel and Lodging | $2,653.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $10,229.74 | 2024-2025 | Rejoyn |
| Alkermes, INC. | $9,684.81 | 2023-2025 | Lybalvi, Aristada, Aristada Initio |
| Acadia Pharmaceuticals INC | $268.26 | 2024-2025 | Nuplazid |
| Sage Therapeutics, LLC | $229.80 | 2022-2025 | Zurzuvae |
| Otsuka America Pharmaceutical, INC. | $161.11 | 2023-2024 | Rexulti |
| Abbvie INC. | $91.40 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $87.12 | 2024-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Biogen, INC. | $77.25 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $64.36 | 2024 | Cobenfy |
| Lundbeck LLC | $47.40 | 2024 | Rexulti |
| Axsome Therapeutics, INC. | $28.45 | 2024 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $25.26 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Penn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.